Login to Your Account

Clinic Roundup

Friday, August 26, 2011
Bionor Pharma ASA, of Oslo, Norway, said it plans to conduct an exploratory study of its HIV vaccine candidate, Vacc-4x, in combination with Revlimid (lenalidomide, Celgene Corp.).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription